Patent US3442883A successfully refreshed from Google Patents.
Patent US5145845A successfully refreshed from Google Patents.
US5145845A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Substituted 2-carboxylindoles having pharmaceutical activity
Assignee: Warner Lambert Co LLC
•
Filing: 1991-05-14
•
Granted: 1992-09-08
•
Expires: 2011-05-14
Abstract
Abstract The present invention relates to novel compounds, which are derivatives of ureas, thioureas, carbamates, sulfonylureas, sulfonamides, amides, and thioamides of 2-carboxyindoles as illustrated by the formula ##STR1## The invention also relates to methods for the preparation of the novel compounds, as well as to pharmaceutical compositions or methods of use for the novel compounds. More specifically, the compounds of the present invention are useful in the treatment of neurodegenerative disorders including cerebrovascular disorders as well as in the treatment of schizophrenia or epilepsy; and as analgesics and anxiolytics.
Inventors
- 👤 Graham Johnson
- 👤 Thomas C. Malone
- 👤 Po-Wai Yuen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 13:30
CPC Classifications
C; C07; C07D; C07D403/00; C07D403/02; C07D403/04; C07D209/00; C07D209/02; C07D209/04; C07D209/30; C07D209/42; C07D403/06
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
551 words
A compound of the formula ##STR16## or a pharmaceutically acceptable base or acid addition salt thereof; wherein (1) Y is (a) OH; (b) OR 30 wherein R 30 is lower alkyl, phenyl, phenylalkyl wherein the alkyl is an alkylene of from one to four carbons and the phenyl is unsubstituted or substituted by from one to three substituents selected from lower alkyl, halogen, trifluoromethyl, nitro, amino, mono- or di-lower alkylamino, hydroxy, lower alkoxy, C(O)OH, and NHCOR 5 wherein R 5 is lower alkyl, lower alkenyl, phenyl, phenylloweralkyl, phenylloweralkenyl or where the phenyl is substituted as defined above; (c) NR 40 R 50 wherein R 40 and R 50 are independently hydrogen or lower alkyl; or (d) OCH 2 OR 30 wherein R 30 is as defined above; (2) R 1 , R 2 , R 3 , and R 4 are independently hydrogen, lower alkyl, halogen, trifluoromethyl, cyano, nitro, methylthio, lower alkenyl, lower alkynyl, SO 2 NH 2 , S(O) 1-2 R wherein R is hydrogen or lower alkyl, OCF 3 ; (3) A is --(CH 2 ) n --, --(CH 2 ) q CH═CH(CH 2 ) p --, ##STR17## wherein R 11 and R 13 are independently as defined below and n is an integer of 0 through 4, q is an integer of 0 or 1, p is an integer of 1 or 2; (4) R 5 is hydrogen, alkyl of from one to twenty carbons, phenyl or phenyl substituted as defined above; (5) R 6 is (a) CONR 8 R 9 , (b) COOR 8 , (c) CSR 8 , (d) S(O) 1-2 R 8 , (e) S(O) 1-2 NR 8 R 9 , or (f) CONR 8 S(O) 1-2 R 9 , wherein R 8 and R 9 are independently (i) hydrogen; (ii) alkyl of from one to twenty carbons, or alkenyl of from one to twenty carbons; (iii) (C 3 -C 6 ) cycloalkyl or (C 3 -C 6 ) cycloalkylloweralkyl; (iv) phenyl or phenyl substituted by one to three of lower alkyl, halogen, trifluoromethyl, nitro, amino, mono- or di-lower alkylamino, hydroxy, lower alkoxy, C(O)OH, NHCOR 10 wherein R 10 is lower alkyl, lower alkenyl, phenyl, phenylloweralkyl, phenylloweralkenyl, or where the phenyl is substituted as defined above, NHSO 2 R 10 wherein R 10 is as defined above, CN, CONR 10 R 11 wherein R 10 is as defined above and R 11 is hydrogen or lower alkyl, or S(O) 0-2 R 10 wherein R 10 is as defined herein; (v) phenylloweralkyl or where the phenyl is substituted as defined above; (vi) phenylloweralkenyl or where the phenyl is substituted as defined above; (vii) (CH 2 ) q R 12 wherein q is an integer of one to four and R 12 is (A) SO 3 R 13 wherein R 13 is hydrogen or lower alkyl, (B) PO 3 R 13 wherein R 13 is as defined above, (C) CO 2 R 13 wherein R 13 is as defined above, or (D) NR 14 R 15 wherein R 14 and R 15 are independently hydrogen or alkyl; or (6) R 5 and R 6 are taken together with N which form ##STR18## wherein m is an integer one or two and R 16 is lower alkyl, phenyl, phenylloweralkyl or where the phenyl is substituted as defined above.
Claim 2
Dependent Claim
551 words
A compound of the formula ##STR16## or a pharmaceutically acceptable base or acid addition salt thereof; wherein (1) Y is (a) OH; (b) OR 30 wherein R 30 is lower alkyl, phenyl, phenylalkyl wherein the alkyl is an alkylene of from one to four carbons and the phenyl is unsubstituted or substituted by from one to three substituents selected from lower alkyl, halogen, trifluoromethyl, nitro, amino, mono- or di-lower alkylamino, hydroxy, lower alkoxy, C(O)OH, and NHCOR 5 wherein R 5 is lower alkyl, lower alkenyl, phenyl, phenylloweralkyl, phenylloweralkenyl or where the phenyl is substituted as defined above; (c) NR 40 R 50 wherein R 40 and R 50 are independently hydrogen or lower alkyl; or (d) OCH 2 OR 30 wherein R 30 is as defined above; (2) R 1 , R 2 , R 3 , and R 4 are independently hydrogen, lower alkyl, halogen, trifluoromethyl, cyano, nitro, methylthio, lower alkenyl, lower alkynyl, SO 2 NH 2 , S(O) 1-2 R wherein R is hydrogen or lower alkyl, OCF 3 ; (3) A is --(CH 2 ) n --, --(CH 2 ) q CH═CH(CH 2 ) p --, ##STR17## wherein R 11 and R 13 are independently as defined below and n is an integer of 0 through 4, q is an integer of 0 or 1, p is an integer of 1 or 2; (4) R 5 is hydrogen, alkyl of from one to twenty carbons, phenyl or phenyl substituted as defined above; (5) R 6 is (a) CONR 8 R 9 , (b) COOR 8 , (c) CSR 8 , (d) S(O) 1-2 R 8 , (e) S(O) 1-2 NR 8 R 9 , or (f) CONR 8 S(O) 1-2 R 9 , wherein R 8 and R 9 are independently (i) hydrogen; (ii) alkyl of from one to twenty carbons, or alkenyl of from one to twenty carbons; (iii) (C 3 -C 6 ) cycloalkyl or (C 3 -C 6 ) cycloalkylloweralkyl; (iv) phenyl or phenyl substituted by one to three of lower alkyl, halogen, trifluoromethyl, nitro, amino, mono- or di-lower alkylamino, hydroxy, lower alkoxy, C(O)OH, NHCOR 10 wherein R 10 is lower alkyl, lower alkenyl, phenyl, phenylloweralkyl, phenylloweralkenyl, or where the phenyl is substituted as defined above, NHSO 2 R 10 wherein R 10 is as defined above, CN, CONR 10 R 11 wherein R 10 is as defined above and R 11 is hydrogen or lower alkyl, or S(O) 0-2 R 10 wherein R 10 is as defined herein; (v) phenylloweralkyl or where the phenyl is substituted as defined above; (vi) phenylloweralkenyl or where the phenyl is substituted as defined above; (vii) (CH 2 ) q R 12 wherein q is an integer of one to four and R 12 is (A) SO 3 R 13 wherein R 13 is hydrogen or lower alkyl, (B) PO 3 R 13 wherein R 13 is as defined above, (C) CO 2 R 13 wherein R 13 is as defined above, or (D) NR 14 R 15 wherein R 14 and R 15 are independently hydrogen or alkyl; or (6) R 5 and R 6 are taken together with N which form ##STR18## wherein m is an integer one or two and R 16 is lower alkyl, phenyl, phenylloweralkyl or where the phenyl is substituted as defined above.
Claim 3
Dependent Claim
9 words
A compound of claim 1 wherein Y is OH.
Claim 4
Dependent Claim
13 words
A compound of claim 1 wherein A is --(CH 2 ) n --.
Claim 5
Dependent Claim
13 words
A compound of claim 1 wherein A is --CH═CH(CH 2 ) 1-2 .
Claim 6
Dependent Claim
13 words
A compound of claim 1 wherein A is --CH 2 CH═CHCH 2 --.
Claim 7
Dependent Claim
9 words
A compound of claim 1 wherein A is ##STR19##
Claim 8
Dependent Claim
14 words
A compound of claim 1 wherein R 6 is CONR 8 R 9 .
Claim 9
Dependent Claim
12 words
A compound of claim 1 wherein R 6 is COOR 8 .
Claim 10
Dependent Claim
12 words
A compound of claim 1 wherein R 6 is CSR 8 .
Claim 11
Dependent Claim
14 words
A compound of claim 1 wherein R 6 is S(O) 1-2 R 8 .
Claim 12
Dependent Claim
16 words
A compound of claim 1 wherein R 6 is S(O) 1-2 NR 8 R 9 .
Claim 13
Dependent Claim
16 words
A compound of claim 1 wherein R 6 is CONR 8 S(O) 1-2 R 9 .
Claim 14
Dependent Claim
17 words
A compound of claim 1 wherein R 5 and R 6 together with the N are ##STR20##
Claim 15
Dependent Claim
88 words
A compound of claim 1 which is (1) Methyl 4,6-dichloro-3-[2-[[(phenylamino)carbonyl]amino]ethyl]-1H-indole-2-carboxylate; (2) Methyl 4,6 dichloro 3-[2 [[[(phenylmethyl)amino]carbonyl]amino]ethyl]-1H-indole-2-carboxylate; (3) Methyl 4,6-dichloro-3-[2-[[[(3,5-dichlorophenyl)amino]carbonyl]amino]ethyl]-1H -indole-2-carboxylate; (4) Methyl 4,6-dichloro 3-[2 [[[(2-methylphenylamino]carbonyl]amino]ethyl]-1H -indole-2 carboxylate; (5) Methyl 4,6-dichloro-3-[2-(2-oxo-3-phenyl 1-imidazolidinyl)ethyl]-1H-indole-2carboxylate; (6) 4,6-Dichloro-3 [2-[[(phenylamino)carbonyl]amino]ethyl]-1H-indole-2-carboxylic acid; (7) 4,6-Dichloro-3-[2-[[[(phenylmethyl)amino]carbonyl]amino]ethyl]-1H-indole-2-carboxylic acid; (8) 4,6-Dichloro-3-[2 [[[(3,5-dichlorophenyl)amino]carbonyl]amino]ethyl]-1H -indole-2-carboxylic acid; (9) 4,6-Dichloro-3-[2 [[[(2-methylphenyl)amino]carbonyl]amino]ethyl]-1H-indole-2-carboxylic acid; (10) 4,6-Dichloro-3 [2 (2 oxo-3 phenyl 1-imidazolidinyl)ethyl]-1H indole-2-carboxylic acid; (11) 4,6-Dichloro-3-[[(phenylamino)carbonyl]amino]-1H indole 2 carboxylic acid; (12) 4,6-Dichloro-3 [[[(phenylamino)carbonyl]amino]methyl]-1H-indole-2-carboxylic acid; (13) 4,6-Dichloro-3-[3-[[(phenylamino)carbonyl]amino]propyl]-1H-indole 2 carboxylic acid; (14) 4,6-Dichloro-3-[3-(2-oxo-3-phenyl-1-imidazolidinyl)propyl]-1H-indole-2-carboxylic acid; (15) 4,6-Dichloro 3-[(2-oxo-3-phenyl-1-imidazolidinyl)methyl]-1H-indole-2-carboxylic acid; (16) 4,6-Dichloro-3-(2-oxo-3-phenyl-1-imidazolidinyl)-1H-indole-2-carboxylic acid; (17) 4,6-Dichloro-3-[[[(phenylsulfonyl)amino]carbonyl]amino]-1H-indole-2-carboxylic acid; and (18) 4,6-Dichloro-3-[2-[[[(phenylsulfonyl)amino]carbonyl]amino]ethyl]-1H-indole-2-carboxylic acid.
Claim 16
Dependent Claim
24 words
A pharmaceutical composition comprising a therapeutically effective amount of a compound of the Formula I of claim 1 together with a pharmaceutically acceptable carrier.
Claim 17
Dependent Claim
39 words
A method for treating disorders responsive to the blockade of glutamic and aspartic acid receptors comprising administration to a patient in need thereof an effective amount of a compound of Formula I of claim 1 in unit dosage form.
References Cited (Backward Citations)
US3182071A
Cited
US3364224A
Cited
US3574737A
Cited
US3472870A
Cited
US4980368A
Cited
US4960786A
Cited
EP0394905A2
Cited
EP0396124A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-09-08 | 1996-03-09 | 1996-09-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-09-08 | 2000-03-09 | 2000-09-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-09-08 | 2004-03-09 | 2004-09-08 | $7700.00 | Window Closed / Lapsed |